These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 27943604)
1. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study. Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study. Hallager S; Ladelund S; Kjaer M; Madsen LG; Belard E; Laursen AL; Gerstoft J; Røge BT; Grønbaek KE; Krarup HB; Christensen PB; Weis N J Viral Hepat; 2018 Jan; 25(1):47-55. PubMed ID: 28750141 [TBL] [Abstract][Full Text] [Related]
3. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. Grønbæk L; Vilstrup H; Jepsen P J Hepatol; 2014 Mar; 60(3):612-7. PubMed ID: 24326217 [TBL] [Abstract][Full Text] [Related]
4. Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010. Chinnaratha MA; Graham C; Fraser RJ; Woodman RJ; Wigg AJ Intern Med J; 2016 Aug; 46(8):902-8. PubMed ID: 27130077 [TBL] [Abstract][Full Text] [Related]
5. Epidemiological trends of hepatocellular carcinoma in Austria. Pinter M; Hucke F; Zielonke N; Trauner M; Sieghart W; Peck-Radosavljevic M Dig Dis; 2014; 32(6):664-9. PubMed ID: 25376282 [TBL] [Abstract][Full Text] [Related]
6. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed. Hong TP; Gow P; Fink M; Dev A; Roberts S; Nicoll A; Lubel J; Kronborg I; Arachchi N; Ryan M; Kemp W; Knight V; Farrugia H; Thursfield V; Desmond P; Thompson AJ; Bell S Hepatology; 2016 Apr; 63(4):1205-12. PubMed ID: 26435297 [TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
8. Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study. Bossen L; Grønbaek H; Lykke Eriksen P; Jepsen P Liver Int; 2017 Jul; 37(7):1042-1046. PubMed ID: 28317318 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survival. Wallace MC; Preen DB; Short MW; Adams LA; Jeffrey GP Liver Int; 2019 Mar; 39(3):522-530. PubMed ID: 30230194 [TBL] [Abstract][Full Text] [Related]
10. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. El-Serag HB; Davila JA Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699 [TBL] [Abstract][Full Text] [Related]
11. Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population-based cohort study. Anyiwe K; Qiao Y; De P; Yoshida EM; Earle CC; Thein HH Liver Int; 2016 Jun; 36(6):902-10. PubMed ID: 26455359 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival. Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986 [TBL] [Abstract][Full Text] [Related]
13. Improving prognosis for patients with hepatocellular carcinoma in Ireland 1994-2008. Gaynor C; Iqbal M; Comber H; Deady S; McCormick PA Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):221-224. PubMed ID: 27832038 [TBL] [Abstract][Full Text] [Related]
14. Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study. Jepsen P; Ott P; Andersen PK; Sørensen HT; Vilstrup H Ann Intern Med; 2012 Jun; 156(12):841-7, W295. PubMed ID: 22711076 [TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
16. Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan. Hung GY; Horng JL; Yen HJ; Lee CY; Lin LY J Hepatol; 2015 Dec; 63(6):1390-6. PubMed ID: 26256438 [TBL] [Abstract][Full Text] [Related]
17. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. Chang PE; Ong WC; Lui HF; Tan CK J Gastroenterol; 2008; 43(11):881-8. PubMed ID: 19012042 [TBL] [Abstract][Full Text] [Related]
18. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis. Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. Altekruse SF; McGlynn KA; Reichman ME J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma over three decades in Victoria, Australia: epidemiology, diagnosis and trends, 1984-2013. Carville KS; MacLachlan JH; Thursfield V; Cowie BC Intern Med J; 2018 Jul; 48(7):835-844. PubMed ID: 29604152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]